Clinical trial

Multicenter Trial of ESK981 in Patients With Select Solid Tumors

NCT05988918

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2024-04-19

PhasePHASE2

Study timeline

Study start (actual)2024-04-19Date precision: day

Registry last updated2026-05-14

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Pancreatic Adenocarcinomaunresolved

Adenosquamous Carcinomaunresolved

Pancreatic Neuroendocrine Tumorunresolved

Pancreatic Neuroendocrine Carcinomaunresolved

Gastrointestinal Neuroendocrine Tumorunresolved

Gastrointestinal Neuroendocrine Carcinomaunresolved

Neuroendocrine Prostate Carcinomaunresolved

Interventions

Sponsors & collaborators

University of Michigan Rogel Cancer Centerlead sponsor

Mapped research locations

Ann ArborMichigan, United States1 MadisonWisconsin, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05988918 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.